Federal law delays 503B outsourcing facilities from backfilling drug shortages
Pharmacy Practice News reports statutory constraints slow outsourcing facilities when they try to supply drugs in short supply.
DO
By Daniel Okafor · Regulatory Correspondent
Oct 14 11:24 ETSource: Pharmacy Practice News
The wire
- 01The report describes how federal law delays 503B outsourcing facilities from standing up backup supply during drug shortages.
- 02Compounders and health-system pharmacies rely on 503B facilities when manufactured products, including peptide drugs, go short.
- 03Details of the statutory fix and any legislative timeline are not laid out in the available text.
From the source
Read at pharmacypracticenews.comDrug Shortages - Federal Law Delays 503B Backup Supply
